Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$2.46 - $4.27 $61,992 - $107,603
-25,200 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$1.65 - $2.48 $41,580 - $62,496
25,200 New
25,200 $62,000
Q2 2018

Aug 08, 2018

SELL
$1.89 - $4.95 $29,295 - $76,725
-15,500 Closed
0 $0
Q1 2018

May 10, 2018

SELL
$2.06 - $2.38 $29,664 - $34,272
-14,400 Reduced 48.16%
15,500 $32,000
Q4 2017

Feb 12, 2018

SELL
$1.91 - $2.83 $58,828 - $87,164
-30,800 Reduced 50.74%
29,900 $62,000
Q3 2017

Nov 13, 2017

BUY
$2.44 - $2.91 $148,108 - $176,637
60,700
60,700 $162,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $366M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.